Cite
[Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center].
MLA
Ngo, Carine, et al. “[Internal Quality Control on HER2 Status Determination in Breast Cancers: Experience of a Cancer Center].” Bulletin Du Cancer, vol. 104, no. 7–8, July 2017, pp. 608–17. EBSCOhost, https://doi.org/10.1016/j.bulcan.2017.05.002.
APA
Ngo, C., Laé, M., Ratour, J., Hamel, F., Taris, C., Caly, M., Le Cunff, A., Reyal, F., Kirova, Y., Pierga, J.-Y., & Vincent-Salomon, A. (2017). [Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center]. Bulletin Du Cancer, 104(7–8), 608–617. https://doi.org/10.1016/j.bulcan.2017.05.002
Chicago
Ngo, Carine, Marick Laé, Julia Ratour, Frédérique Hamel, Corinne Taris, Martial Caly, Annie Le Cunff, et al. 2017. “[Internal Quality Control on HER2 Status Determination in Breast Cancers: Experience of a Cancer Center].” Bulletin Du Cancer 104 (7–8): 608–17. doi:10.1016/j.bulcan.2017.05.002.